Microparticle structure of Lycopodium clavatum peptide fermentation product
Patent Information
- Application Number
- TW115204957
- Authority / Receiving Office
- TW · TW
- Patent Type
- Utility models
- Current Assignee / Owner
- Filing Date
- 2026-05-29
- Publication Date
- 2026-11-11
- Estimated Expiration
- 2036-05-28
Smart Images

Figure TWG2TB001921244_001 
Figure TWG2TB001921244_002 
Figure TWG2TB001921244_003
Abstract
Claims
1. A microparticle structure of a *Lycopodium clavatum* peptide ferment, the microparticle structure comprising: a microparticle carrier, which is a core entity formed by structuring a *Lycopodium clavatum* peptide ferment; an exosome unit, which is a plurality of vesicles dispersed within or on the surface of the microparticle carrier; a *Lycopodium clavatum* peptide unit, which is a plurality of chain-like molecules interwoven within or on the surface of the microparticle carrier; and a protective layer having a three-dimensional closed network structure and covering the periphery of the microparticle carrier to restrict the spatial displacement of the exosome unit and the *Lycopodium clavatum* peptide unit.
2. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 1, wherein the detection concentration of the exosome unit in the microparticle structure is greater than 1 × 10¹² p / g.
3. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 2, wherein the detection concentration of the exosome unit in the microparticle structure is 9.5 × 10¹² p / g.
4. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 1, wherein the molecular weight of the *Lycopodium clavatum* peptide unit is less than 3 kDa.
5. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 1, wherein the mass percentage of the *Lycopodium clavatum* peptide unit in the microparticle structure is greater than 10%.
6. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 5, wherein the mass percentage of the *Lycopodium clavatum* peptide unit in the microparticle structure is 10.08%.
7. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 1, which has the property of reducing the expression of the inflammatory hormone IL-1β in an inflamed muscle cell by up to 40% when applied to the muscle cell.
8. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 1, which has the property of reducing the expression of the inflammatory hormone IL-6 in an inflamed muscle cell by up to 87% when applied to the muscle cell.
9. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 1, which has the property of increasing the activity of the antioxidant enzyme SOD in a muscle cell by 72% when applied to a muscle cell under high oxidative stress.
